Investment Stage

Focus Areas

About Investor

Sharaf Yamani currently serves as Managing Director at Windlesham Advisors and is an active angel investor focusing on Pharmaceuticals, TransportationTech, EnergyTech, Space, BioTech, and Drug Delivery sectors, typically investing at Seed stage with amounts ranging from $5K to $50K. His professional background includes his leadership role at Windlesham Advisors, bringing strategic advisory experience to his investment activities. Yamani has established himself as an angel investor with particular interest in highly innovative companies in healthcare, technology, and industrial sectors, supporting ventures that aim to address significant challenges through technological innovation.